Benign prostatic hyperplasia requiring transurethral resection of the prostate in a 60-year-old male-to-female transsexual

British Journal of Urology

Volumn 80, Issue 6, 1997, Pages 956-957

  Brown, J A ^a,b,c   Wilson, T M ^a,b,c  

^a MAYO CLINIC   (United States)

^b DAVID GRANT MEDICAL CENTER   (United States)

^c Department of Urology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTR 4 EN 17BETA OL; ESTROGEN; MEDROXYPROGESTERONE ACETATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CYSTOSCOPY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TRANSSEXUALISM; TRANSURETHRAL RESECTION; URINALYSIS;

EID: 0031396963     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00342.x     Document Type: Article

References (6)

1. Geller J. Nonsurgical treatment of prostatic hyperplasia. Cancer 1992; 70 (Suppl): 339-45
2. Geller J, Sionit L. Castration-like effects on the human prostate of a five alpha-reductase inhibitor, finasteride. J Cell Biochem 1992; Suppl 16H: 109-12
3. Yokoyama M, Seki N, Tamai M, Takeuchi M. Benign prostatic hyperplasia in a patient castrated in his youth. J Urol 1989; 142: 134-5
4. Geller J. Overview of benign prostatic hypertrophy. Urology 1989; 34: 57-63, discussion 87-96
5. Goodwin WE, Cummings RH. Squamous metaplasia of the verumontanum with obstruction due to hypertrophy: long-term effects of estrogen on the prostate in an aging male-to-female transsexual. J Urol 1984; 131: 553-4
6. Wilson JD. The pathogenesis of benign prostatic hyperplasia. Am J Med 1980; 68: 745-56